Sit Swan - Insider Non-Derivative Transactions at NovaBay Pharmaceuticals, Inc. (NBY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 11, 2023, Sit Swan's relationship to NovaBay Pharmaceuticals, Inc. (NBY) is Director, and currently has 1,716 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NBY insiders.
Data Source: SEC.
Sit Swan - Insider Non-Derivative Transactions at NBY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 12, 2023 | M -- (Common Stock) | 858 | 0 | 1716 |